Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126240411 | 12624041 | 1 | I | 2008 | 20160616 | 20160804 | 20160804 | PER | US-ASTRAZENECA-2016SE67231 | ASTRAZENECA | 50.00 | YR | F | Y | 94.30000 | KG | 20160805 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126240411 | 12624041 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 3655 | UG | U | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||
| 126240411 | 12624041 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 73080 | MG | 0 | 40 | MG | TABLET | QD | |||||
| 126240411 | 12624041 | 3 | C | CLONODINE HCL | 2 | Oral | 0 | 3 | MG | BID | |||||||||
| 126240411 | 12624041 | 4 | C | LABETALOL | LABETALOLLABETALOL HYDROCHLORIDE | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 126240411 | 12624041 | 5 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | BID | ||||||||
| 126240411 | 12624041 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 126240411 | 12624041 | 7 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 126240411 | 12624041 | 8 | C | AMYTRIPTYLINE | 2 | Oral | 0 | 50 | MG | QD | |||||||||
| 126240411 | 12624041 | 9 | C | PROVASTATIN | 2 | Oral | 0 | 40 | MG | QD | |||||||||
| 126240411 | 12624041 | 10 | C | EUPUTROTRON HCL XL | 2 | Oral | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126240411 | 12624041 | 1 | Type 2 diabetes mellitus |
| 126240411 | 12624041 | 2 | Hypertension |
| 126240411 | 12624041 | 3 | Hypertension |
| 126240411 | 12624041 | 4 | Hypertension |
| 126240411 | 12624041 | 5 | Hypertension |
| 126240411 | 12624041 | 6 | Type 2 diabetes mellitus |
| 126240411 | 12624041 | 7 | Gout |
| 126240411 | 12624041 | 8 | Insomnia |
| 126240411 | 12624041 | 9 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126240411 | 12624041 | Blood cholesterol increased | |
| 126240411 | 12624041 | Blood glucose increased | |
| 126240411 | 12624041 | Device failure | |
| 126240411 | 12624041 | Diabetes mellitus | |
| 126240411 | 12624041 | Drug dose omission | |
| 126240411 | 12624041 | Gout | |
| 126240411 | 12624041 | Incorrect dose administered | |
| 126240411 | 12624041 | Tremor | |
| 126240411 | 12624041 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126240411 | 12624041 | 1 | 2012 | 0 | ||
| 126240411 | 12624041 | 2 | 2008 | 0 | ||
| 126240411 | 12624041 | 3 | 2008 | 0 | ||
| 126240411 | 12624041 | 4 | 2008 | 0 | ||
| 126240411 | 12624041 | 5 | 2008 | 0 | ||
| 126240411 | 12624041 | 6 | 2012 | 0 | ||
| 126240411 | 12624041 | 7 | 2013 | 0 | ||
| 126240411 | 12624041 | 9 | 2008 | 0 | ||
| 126240411 | 12624041 | 10 | 2008 | 0 |